Haspin: a promising target for the design of inhibators as potent anticancers drugs

dc.contributor.authorAMOUSSOU, NATHALIE GISELE
dc.contributor.authorBIGOT, KOFFI ANDRÉ
dc.contributor.authorRoussakis, CHRISTOS
dc.contributor.authorRobert, Jean-Michel H.
dc.date.accessioned2026-06-02T16:06:57Z
dc.date.available2026-06-02T16:06:57Z
dc.date.issued2017
dc.description.abstractProtein kinases constitute a large group of enzymes in eukaryotes and have an important role in many cellular processes. Several of these proteins are active kinases, such as haploid germ cell-specific nudear protein kinase (Haspin), an atypical eukaryotic protein kinase that lacks sequence similarity with other eukaryotic protein kinases. Haspin is a serine/threonine kinase that associa tes with chromosome and phosphorylates threonine 3 of histone 3 during mitosis. Haspin overexpression or deletion results in defective mitosis. It has been shown that Haspin inhibitors have potent anti-tumoral effects. Given that the only Haspin substrate is threonine 3 of histone 3, inhibition of Haspin might have fewer adverse QZ effects compared with XXXX. Here, we highlight the chemical structures and actions of currently known Haspin inhibitoTs.
dc.identifier.otherBECDB-7178
dc.identifier.urihttps://dspace.uac.bj/handle/123456789/6475
dc.language.isofr
dc.relation.ispartofDrug Dlseovery TodaY
dc.subjectHaspin
dc.subjectinhibators
dc.subjectanticancers
dc.subjectdrugs
dc.titleHaspin: a promising target for the design of inhibators as potent anticancers drugs
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
d8416ef28949752a9964343c298ebaf3.pdf
Size:
1.32 MB
Format:
Adobe Portable Document Format

Collections